GO
Loading...

Acquisitions

More

  • NEW YORK and LOS ANGELES, July 1- Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.

  • Stocks rise as surveys show stronger manufacturing Tuesday, 1 Jul 2014 | 9:16 AM ET

    Netflix jumped after analysts at Goldman Sachs raised their outlook on the stock. Sanofi and Regeneron are collaborating on drug research and have an agreement that Sanofi won't acquire more than a 30 percent stake in the company.

  • Stryker buys joint device maker for up to $375M Monday, 30 Jun 2014 | 10:32 AM ET

    NEW YORK— Medical device maker Stryker said Monday it will buy bone and joint replacement maker Small Bone Innovations for up to $375 million in cash. Small Bone Innovations is based in Morrisville, Pennsylvania, with facilities in France and Germany. Shares of Stryker Corp. rose 28 cents to $84.25 in afternoon trading.

  • Under Chief Executive Frans van Houten, the Dutch company- which started out 120 years ago as a pioneer in electric lighting- has been shifting away from the consumer electronics sector in a restructuring which has involved more than 5,000 job cuts and the sale of its television business.

  • June 26- Private-label food retailer TreeHouse Foods Inc is in late-stage talks to acquire Flagstone Foods, a maker of dried fruits and nuts, for between $800 million and $900 million, people familiar with the matter said on Thursday.

  • *Combined company will have about $1.4 bln annual sales. FRANKFURT, June 26- Austria's AMS is in talks to buy German peer Dialog Semiconductor to create a European chipmaker with a market value of about $4.7 billion that could better tap the growing market for web-connected devices.

  • June 26- Auxilium Pharmaceuticals Inc would buy Canadian drugmaker QLT Inc in a deal valued at about $850 million to add QLT's experimental treatment for eye diseases caused by gene mutations. Auxilium shares were up 18 percent at $25 in premarket trade, while QLT's U.S.-listed shares rose 30 percent to $7.

  • Auxilium Pharma to buy Canadian eye drug maker QLT Thursday, 26 Jun 2014 | 7:30 AM ET

    June 26- Auxilium Pharmaceuticals Inc said it would buy Canadian eye drug maker QLT Inc in an all-stock deal to gain access to QLT's experimental treatment for retinal diseases caused by gene mutations.

  • Cancer drug setback tarnishes AstraZeneca's R&D claims Thursday, 26 Jun 2014 | 6:31 AM ET

    *AstraZeneca mis-steps may revive prospects of takeover. LONDON, June 26- A vote by U.S. experts against accelerated approval of a new ovarian cancer drug from AstraZeneca has dented its claims of research prowess, which were used to see off a $118 billion bid from Pfizer.

  • LONDON, June 26- The London Stock Exchange Group said it planned to acquire U.S.-based asset manager and stock exchange provider Frank Russell for $2.7 billion, with the help of a $1.6 billion rights issue, as it ramps up its U.S. presence.

  • *Says deal would boost new AbbVie's adjusted EPS materially. LONDON, June 25- U.S. drugmaker AbbVie said on Wednesday it wanted to move rapidly to clinch a takeover of Shire as it set out the strategic rationale for buying the London- listed company, which has spurned its $46 billion offer.

  • LONDON, June 25- U.S. drugmaker AbbVie set out the strategic rationale for acquiring Shire on Wednesday as a battle for control of the London- listed company, which has spurned AbbVie's $46 billion bid, entered a new phase.

  • *Move bolsters Shire in defence against AbbVie. *AbbVie to put its case to Shire shareholders- source. LONDON, June 25- Shire, which has spurned a $46 billion takeover offer from U.S. group AbbVie as inadequate, has a new reason to argue it is worth more after a U.S. court backed patent claims on its top-selling drug Vyvanse.

  • *Syngenta declines to comment on report of Monsanto talks. ZURICH, June 24- Syngenta's shares jumped on Tuesday after a media report that the Swiss crop chemical maker had been in talks about a $40 billion takeover by U.S. rival Monsanto Co to create the world's largest agrochemical company.

  • TORONTO, June 24- Two large groups of investors that control roughly 20 percent of the shares of Tuckamore Capital Management Inc have gone public with their discontent over a management-led buyout of the firm, being sponsored by Birch Hill, a private equity player.

  • LONDON/ MADRID, June 24- Private equity firm KKR is to buy a one-third stake in indebted Spanish group Acciona's international wind farms arm for 417 million euros, the companies said on Tuesday, with a view to listing the business next year.

  • Death of the desktop?     Tuesday, 24 Jun 2014 | 8:37 AM ET

    Scott McNealy, Sun Microsystems co-founder, shares his thoughts on the future of the PC and the "Internet of things."

  • McNealy: IRS email loss 'stunning'     Tuesday, 24 Jun 2014 | 8:33 AM ET

    How in the day and age of the cloud and back-up could this happen, asks Scott McNealy, Sun Microsystems co-founder, sharing his frustration with the IRS losing emails.

  • LONDON/ MADRID, June 24- Private equity firm KKR is to buy a one-third stake in the energy arm of Spain's Acciona for 417 million euros, the companies said on Tuesday, as they move to develop one of the world's largest renewable energy portfolios. The government measures have particularly hurt profit at Acciona's wind farms.

  • Franklin Lakes, New Jersey- based Western World offers auto and property insurance and, within Validus, it will operate as an independent business led by its current management team. Validus provides reinsurance and insurance services and operates through its three Bermuda- based units- Reinsurance Ltd, Talbot Holdings Ltd and AlphaCat Managers Ltd..